Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude

Chest

Volumn 147, Issue 1, 2015, Pages 120-131

  Caravita, Sergio ^a,b   Faini, Andrea ^a   Lombardi, Carolina ^a   Valentini, Mariaconsuelo ^a   Gregorini, Francesca ^a   Rossi, Jessica ^a   Meriggi, Paolo ^c   Di Rienzo, Marco ^c   Bilo, Grzegorz ^a   Agostoni, Piergiuseppe ^d,e   Parati, Gianfranco ^a,b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^d CENTRO CARDIOLOGICO MONZINO   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; PLACEBO; CARBONATE DEHYDRATASE INHIBITOR;

ADULT; ALTITUDE; ARTICLE; BREATHING DISORDER; BREATHING PATTERN; CARBON DIOXIDE BREATHING; CARDIORESPIRATORY FITNESS; CHEMORECEPTOR REFLEX; CHEMOSENSITIVITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; HYPERCAPNIA; HYPOXIA; LUNG VENTILATION; MALE; NOCTURNAL PERIODIC BREATHING; OXYGEN CONSUMPTION; OXYGENATION; RANDOMIZED CONTROLLED TRIAL; SEA LEVEL; SEX DIFFERENCE; ANOXIA; CHEMORECEPTOR CELL; DOSE RESPONSE; DRUG EFFECTS; FOLLOW UP; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYSOMNOGRAPHY; SLEEP;

ACETAZOLAMIDE; ADULT; ALTITUDE; ANOXIA; CARBONIC ANHYDRASE INHIBITORS; CHEMORECEPTOR CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCAPNIA; MALE; OXYGEN CONSUMPTION; POLYSOMNOGRAPHY; SLEEP;

EID: 84920722556     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0317     Document Type: Article

References (52)

1. Sutton JR, Houston CS, Mansell AL, et al. Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med. 1979; 301 (24): 1329-1331.
2. Hackett PH, Roach RC, Harrison GL, Schoene RB, Mills WJ Jr. Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am Rev Respir Dis. 1987; 135 (4): 896-898.
3. Lombardi C, Meriggi P, Agostoni P, et al; HIGHCARE Investigators. High-altitude hypoxia and periodic breathing during sleep: gender-related differences. J Sleep Res. 2013; 22 (3): 322-330.
4. Somers VK, White DP, Amin R, et al; American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008; 118 (10): 1080-1111.
5. Kasai T, Floras JS, Bradley TD. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation. 2012; 126 (12): 1495-1510.
6. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999; 160 (4): 1101-1106.
7. Lanfranchi PA, Somers VK, Braghiroli A, Corra U, Eleuteri E, Giannuzzi P. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation. 2003; 107 (5): 727-732.
8. Giannoni A, Emdin M, Poletti R, et al. Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. Clin Sci (Lond). 2008; 114 (7): 489-497.
9. Apostolo A, Agostoni P, Contini M, Antonioli L, Swenson ER. Acetazolamide and inhaled carbon dioxide reduce periodic breathing during exercise in patients with chronic heart failure. J Card Fail. 2014; 20 (4): 278-288.
10. Lahiri S, Maret K, Sherpa MG. Dependence of high altitude sleep apnea on ventilatory sensitivity to hypoxia. Respir Physiol. 1983; 52 (3): 281-301.
11. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a doubleblind, prospective study. Am J Respir Crit Care Med. 2006; 173 (2): 234-237.
12. Fontana M, Emdin M, Giannoni A, Iudice G, Baruah R, Passino C. Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. Am J Cardiol. 2011; 107 (11): 1675-1680.
13. White DP, Zwillich CW, Pickett CK, Douglas NJ, Findley LJ, Weil JV. Central sleep apnea. Improvement with acetazolamide therapy. Arch Intern Med. 1982; 142 (10): 1816-1819.
14. DeBacker WA, Verbraecken J, Willemen M, Wittesaele W, DeCock W, Van de Heyning P. Central apnea index decreases aft er prolonged treatment with acetazolamide. A m J Respir Crit Care Med. 1995; 151 (1): 87-91.
15. Latshang TD, Nussbaumer-Ochsner Y, Henn RM, et al. Effect of acetazolamide and auto CPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial. JAMA. 2012; 308 (22): 2390-2398.
16. 2) sensitivity? Am J Respir Crit Care Med. 1999; 160(5 pt 1): 1592-1597.
17. Parati G, Revera M, Giuliano A, et al. Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure. Eur Heart J. 2013; 34 (10): 759-766.
18. Salvi P, Revera M, Faini A, et al. Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide. Hypertension. 2013; 61 (4): 793-799.
19. Agostoni P, Swenson ER, Fumagalli R, et al. Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project. Respir Physiol Neurobiol. 2013; 188 (2): 223-228.
20. Roach RC, Bartsch P, Hackett PH, et al. The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates A, eds. Hypoxia and Molecular Medicine. Burlington, VT : Queen City Printers, Inc; 1993 : 272-274.
21. Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol (1985). 2007; 102 (4): 1313-1322.
22. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol (1985). 1989; 67 (5): 2101-2106.
23. Narkiewicz K, Pesek CA, van de Borne PJ, Kato M, Somers VK. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation. 1999; 100 (3): 262-267.
24. Teppema LJ, Dahan A. The ventilatory response to hypoxia in mammals: mechanisms, measurement, and analysis. Physiol Rev. 2010; 90 (2): 675-754.
25. Napoli AM, Milzman DP, Damergis JA, Machan J. Physiologic affects of altitude on recreational climbers. Am J Emerg Med. 2009; 27 (9): 1081-1084.
26. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979; 6 : 65-70.
27. Teppema LJ, Balanos GM, Steinback CD, et al. Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. Am J Respir Crit Care Med. 2007; 175(3): 277-281.
28. Blain GM, Smith CA, Henderson KS, Dempsey JA. Peripheral chemoreceptors determine the respiratory sensitivity of central chemoreceptors to CO(2). J Physiol. 2010; 588 (pt 13): 2455-2471.
29. Plataki M, Sands SA, Malhotra A. Clinical consequences of altered chemoreflex control. Respir Physiol Neurobiol. 2013; 189 (2): 354-363.
30. Cherniack NS, Longobardo GS. Mathematical models of periodic breathing and their usefulness in understanding cardiovascular and respiratory disorders. Exp Physiol. 2006; 91 (2): 295-305.
31. Saaresranta T, Polo O. Hormones and breathing. Chest. 2002; 122 (6): 2165-2182.
32. Behan M, Wenninger JM. Sex steroidal hormones and respiratory control. Respir Physiol Neurobiol. 2008; 164 (1-2): 213-221.
33. Macnutt MJ, De Souza MJ, Tomczak SE, Homer JL, Sheel AW. Resting and exercise ventilatory chemosensitivity across the menstrual cycle. J Appl Physiol (1985). 2012; 112 (5): 737-747.
34. Bhaumik G, Sharma RP, Dass D, et al. Hypoxic ventilatory response changes of men and women 6 to 7 days aft er climbing from 2100 m to 4350 m altitude and aft er descent. High Alt Med Biol. 2003; 4 (3): 341-348.
35. Regensteiner JG, Pickett CK, McCullough RE, Weil JV, Moore LG. Possible gender differences in the effect of exercise on hypoxic ventilatory response. Respiration. 1988; 53 (3): 158-165.
36. Morelli C, Badr MS, Mateika JH. Ventilatory responses to carbon dioxide at low and high levels of oxygen are elevated aft er episodic hypoxia in men compared with women. J Appl Physiol (1985). 2004; 97 (5): 1673-1680.
37. 2 inhalation in Caucasians. Respir Physiol. 1972; 16 (3): 337-350.
38. van Klaveren RJ, Demedts M. Determinants of the hypercapnic and hypoxic response in normal man. Respir Physiol. 1998; 113 (2): 157-165.
39. White DP, Douglas NJ, Pickett CK, Weil JV, Zwillich CW. Sexual influence on the control of breathing. J Appl Physiol. 1983; 54 (4): 874-879.
40. White DP, Schneider BK, Santen RJ, et al. Influence of testosterone on ventilation and chemosensitivity in male subjects. J Appl Physiol (1985). 1985; 59 (5): 1452-1457.
41. Aitken ML, Franklin JL, Pierson DJ, Schoene RB. Influence of body size and gender on control of ventilation. J Appl Physiol (1985). 1986; 60 (6): 1894-1899.
42. Jensen D, Wolfe LA, O'Donnell DE, Davies GA. Chemoreflex control of breathing during wakefulness in healthy men and women. J Appl Physiol (1985). 2005; 98 (3): 822-828.
43. Bärtsch P, Swenson ER, Paul A, Jülg B, Hohenhaus E. Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness. High Alt Med Biol. 2002; 3 (4): 361-376.
44. Maxwell DL, Cover D, Hughes JM. Effect of respiratory apparatus on timing and depth of breathing in man. Respir Physiol. 1985; 61 (2): 255-264.
45. Swenson ER, Teppema LJ. Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story. J Appl Physiol (1985). 2007; 102 (4): 1305-1307.
46. Pickerodt PA, Francis RC, Höhne C, et al. Pulmonary vasodilation by acetazolamide during hypoxia: impact of methyl-group substitutions and administration route in conscious, spontaneously breathing dogs. J Appl Physiol (1985). 2014; 116 (7): 715-723.
47. Lahiri S. Dynamic aspects of regulation of ventilation in man during acclimatization to high altitude. Respir Physiol. 1972; 16 (2): 245-258.
48. Douglas NJ, White DP, Weil JV, et al. Hypoxic ventilatory response decreases during sleep in normal men. Am Rev Respir Dis. 1982; 125 (3): 286-289.
49. Douglas NJ, White DP, Weil JV, Pickett CK, Zwillich CW. Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis. 1982; 126 (5): 758-762.
50. Zhou XS, Shahabuddin S, Zahn BR, Babcock MA, Badr MS. Effect of gender on the development of hypocapnic apnea/hypopnea during NREM sleep. J Appl Physiol (1985). 2000; 89 (1): 192-199.
51. Beidleman BA, Rock PB, Muza SR, Fulco CS, Forte VA Jr, Cymerman A. Exercise VE and physical performance at altitude are not affected by menstrual cycle phase. J Appl Physiol (1985). 1999; 86 (5): 1519-1526.
52. Slatkovska L, Jensen D, Davies GA, Wolfe LA. Phasic menstrual cycle effects on the control of breathing in healthy women. Respir Physiol Neurobiol. 2006; 154 (3): 379-388.